181 related articles for article (PubMed ID: 28879581)
1. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.
Goldman S; Prior SM; Bembenek JP; Niewada M; Broniatowska E; Członkowska A; Butenas S; Undas A
J Thromb Thrombolysis; 2017 Oct; 44(3):362-370. PubMed ID: 28879581
[TBL] [Abstract][Full Text] [Related]
2. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis.
Dong X; Nao J; Gao Y
Neurotox Res; 2020 Feb; 37(2):469-477. PubMed ID: 31478125
[TBL] [Abstract][Full Text] [Related]
5. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of coagulation factor XIII on bleeding risk in ischemic stroke patients treated with intravenous thrombolysis.
Zhang L; Zhang C; Luo Y; Tang N
Ann Palliat Med; 2021 Jul; 10(7):7579-7586. PubMed ID: 34353045
[TBL] [Abstract][Full Text] [Related]
7. Correlation between factor (F)XIa, FIXa and tissue factor and trauma severity.
Prior SM; Cohen MJ; Conroy AS; Nelson MF; Kornblith LZ; Howard BM; Butenas S
J Trauma Acute Care Surg; 2017 Jun; 82(6):1073-1079. PubMed ID: 28328676
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.
Terkelsen T; Schmitz ML; Simonsen CZ; Hundborg HH; Christensen HK; Gyllenborg J; Sandal BF; Iversen HK; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
Int J Stroke; 2016 Oct; 11(8):910-916. PubMed ID: 27312677
[TBL] [Abstract][Full Text] [Related]
9. Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.
Shupp JW; Prior SM; Jo DY; Moffatt LT; Mann KG; Butenas S
Burns; 2018 Mar; 44(2):436-444. PubMed ID: 29032977
[TBL] [Abstract][Full Text] [Related]
10. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
Jucevičiūtė N; Mikužis P; Balnytė R
BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients.
Ząbczyk M; Butenas S; Plicner D; Fijorek K; Sadowski J; Undas A
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):189-94. PubMed ID: 22343680
[TBL] [Abstract][Full Text] [Related]
12. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: a pilot study.
Kurzepa J; Szpetnar M; Hordyjewska A; Wątroba S; Gołąb P; Boguszewska-Czubara A
Neurol Res; 2015 Oct; 37(10):934-7. PubMed ID: 26005019
[TBL] [Abstract][Full Text] [Related]
14. Efforts to reduce the door-to-needle time of thrombolysis in acute ischemic stroke: video-assisted therapeutic risk communication.
Hsieh CY; Chen WF; Chen CH; Wang CY; Chen CJ; Lai EC; Chen TS
J Formos Med Assoc; 2014 Dec; 113(12):929-33. PubMed ID: 24412584
[TBL] [Abstract][Full Text] [Related]
15. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
16. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study.
Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B
Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165
[TBL] [Abstract][Full Text] [Related]
17. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
18. Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.
Hudák R; Székely EG; Kovács KR; Nagy A; Hofgárt G; Berényi E; Csiba L; Kappelmayer J; Bagoly Z
PLoS One; 2017; 12(7):e0180477. PubMed ID: 28692682
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.
Adeoye O; Hornung R; Khatri P; Kleindorfer D
Stroke; 2011 Jul; 42(7):1952-5. PubMed ID: 21636813
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke.
Zhang S; Cao Y; Du J; Liu H; Chen X; Li M; Xiang M; Wang C; Wu X; Liu L; Wang C; Wu Y; Li Z; Fang S; Shi J; Wang L
FASEB J; 2021 Sep; 35(9):e21835. PubMed ID: 34449927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
